The family of a 17-year-old Texas cheerleader has filed a wrongful death lawsuit against a distributor of a popular energy ...

A yearlong investigation found K2-laced “paper hits” driving violence and deaths — while smuggling persists despite costly ...

The U.S. Food and Drug Administration (USFDA) has issued a warning to ImmunityBio, stating that its promotional materials for ...

Study investigators cautioned against routine use of the device in complex percutaneous coronary interventions and to treat ...

"As CMS Launches its $500 Cannabinoid "Engagement Incentive," MMJ International Holdings Warns of a Regulatory "Double ...

Subjects dosed in Phase 1 study evaluating safety and tolerability of a first-in-class multispecific antibodyWESTON, Mass., April 08, 2026 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health ...

Innovation in biologics, digital health tools, and region-specific strategies present major opportunities in veterinary ...

Confirmed, pooled, blinded COVID-19 events in the ongoing Phase 3 DECLARATION study of VYD2311 accumulated to date (~ 50% of study progress) can ...

Deputy Attorney General Todd Blanche go now work as acting attorney general, while di Trump administration go give Bondi new ...

Cheap fish may be good for your grocery budget, but it can come back to bite you in other ways. Think twice before buying and ...

EU grants marketing approval to ALK’s EURneffy 1 mg, a needle-free adrenaline treatment for young children at risk of anaphylaxis: Denmark Thursday, April 2, 2026, 13:00 Hrs [IS ...

ModeX Therapeutics initiates patient dosing in phase 1 trial of MDX2301 for the prevention of Covid-19: Weston, Massachusetts Thursday, April 9, 2026, 18:00 Hrs [IST] ModeX Therap ...